ASIC drops 12% in a week while peers gain: what changed
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Ategrity Specialty Insurance has shed 11.6% over the past week to close at $23.92, a sharp reversal from the $27.60 it held when the previous earnings preview was published on October 21. That move is hard to explain through positioning alone: peers including AXS, WTM and PLMR all gained 2% to 3% over the same period, making ASIC's slide the clear outlier in the specialty insurance group.
The selloff has coincided with a shift in analyst tone. JP Morgan trimmed its price target from $29 to $27 on October 26, keeping an Overweight rating. Barclays and Wells Fargo both cut their targets on October 22, to $27 and $29 respectively, also holding Overweight. The mean target now stands at $28.40, implying roughly 19% upside to the current price. That gap widened not because analysts turned bearish but because the stock fell sharply while the Street kept positive ratings in place. Citigroup, the sole Neutral in the mix, actually raised its target to $29 from $28.50 on October 22. The direction of analyst revisions has turned cautious, but the underlying conviction remains constructive.
Short positioning does not explain the move. Short interest is under 0.6% of the free float, and has fallen about 9% over the past week as the stock dropped. Borrow costs remain negligible at 0.55%, with availability at roughly 1,691%, meaning the pool of shares available to lend dwarfs the current short position by a factor of around 17. Bears have not built a position into this print; the selling pressure has come from somewhere else.
The earnings history adds context. The last quarterly print, on October 21, sent the stock down 13.8% in a single session. The result before that, in late July, produced a 6.8% decline. Two consecutive negative reactions suggest the market has been disappointed by what the numbers have shown, even as analysts maintained positive ratings throughout. At a price-to-earnings multiple of just under 10 and a price-to-book of 1.49, both down meaningfully over the past week, valuation has compressed sharply into this release.
The October 29 print is therefore a test of whether the recent target cuts from JP Morgan, Barclays and Wells Fargo were sufficient to reset expectations, or whether the pattern of post-earnings declines reflects something structural in the underlying loss ratios or reserve development that the current consensus has yet to fully capture.
Stocks in this article
See the live data behind this article on ORTEX.
Open ASIC on ORTEX →How this article was generated
- Generated
- 27 Oct 2026, 04:48
- Data as of
- 27 Oct 2026, 04:03
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.